The United States is one of the most dangerous high-income countries in which to give birth. Nearly every negative maternal health outcome impacts women of color more than white women. This February, in honor of Heart Health Month and Black History Month, Truveta released new research around maternal health and racial disparities.

On February 14, we held a LinkedIn Live with Director of Epidemiology Charlotte Baker, DrPH, MPH, CPH, and Chief Medical Officer and VP of Product Management Michael Simonov, MD. Dr. Baker and Dr. Simonov spoke about the team’s most recent, important maternal heart health insights, and they shared how Truveta accelerates the speed of medical research discovery with daily updated data.

In this session, they talked about how to use Truveta Studio to define complex medical conditions with Truveta Prose to create data definitions covering thousands of conditions as diverse as defining pregnancy, heart failure, cystic fibrosis, diabetes, and more. The ability to define these complex conditions quickly and make them computable not only speeds time to insight, but also enables collaboration among researchers to ensure the transparency and reproducibility of their studies. They also discussed the ways Truveta Studio makes research faster and easier with timely, representative, and complete data, touching on the research made possible with full patient journeys including medication data, claims, clinical notes and more.

Watch the LinkedIn Live for details on the maternal heart health research, specifics on Truveta Studio, and to hear about what Dr. Baker and Dr. Simonov are looking forward to working on next.


To learn more about Truveta Studio, contact us for a demo below.